Featured

Rippl Acquires Kinto

Today Rippl, a leading dementia-focused specialty care provider, announced it has acquired Kinto, a Boston-based,... Read more »

Ginkgo Bioworks Acquires Modulus Therapeutics

Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity,... Read more »

Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners

Steve Holtzclaw, MD, MBA, is the CEO of U.S. Orthopaedic Partners, a position he assumed on January 1, 2024... Read more »

citybiz
Gain exposure through our multi-channel news platform.

Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline

Krystal Biotech: VYJUVEK’s Blockbuster Potential In Gene Therapy For DEB

Office Practicum And GoCheck Kids To Partner

An Update On Ascendis Pharma’s Path To Profitability

Summit Therapeutics’ Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer

2024’s Best & Worst States for Nurses – WalletHub Study

Planet Fitness Lake Stevens Hosting Grand Opening, Apr. 24

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

Healthiest Cities in America (2024 Rankings) – WalletHub Study

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

2024’s Best & Worst States for Doctors – WalletHub Study

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’

2024’s Most Overweight and Obese Cities in the U.S. – WalletHub Study

Pfizer Stock: It’s Time To Buy The Dip

Immunome to Acquire AL102

Clear Secure: Stronger Travel Demand And Softer Dilution To Provide Momentum